1-((2-(Trimethylsilyl)ethoxy)methyl)-1H-pyrrolo[2,3-b]pyridin-2(3H)-one, 95.0%, 25g

tert-Butyl 4-(2-(methylamino)ethyl)piperazine-1-carboxylate, 95.0%, 100mg

2,2'-(9H-fluorene-9,9-diyl)diethanol, 97.0%, 10g

2-(Dimethylamino)ethyl Acrylate (stabilized with MEHQ)>98.0%(GC)100g

2,3-Dichloro-6-methoxyquinoxaline, 95.0%, 10g

2-(4-CYCLOPROPYLPHENYL)ACETIC ACID, 95.0%, 5g

Tripropylene Glycol (mixture of isomers)>98.0%(GC)500mL

Azobenzene-4,4'-dicarboxylic Acid>95.0%(HPLC)(T)1g

3-((tert-Butoxycarbonyl)amino)-5-hydroxybenzoic acid, 95.0%, 1g

Propanamide, N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-2-thiazolyl]-1-pyrrolidinyl]-2-oxoethyl]-2-(methylamino)-, (2S)-, 99%, 100mg

1-Bromo-2-chloro-3-methoxy-5-methylbenzene, 98%, 250mg

3-(3-Fluoro-4-methoxyphenyl)propanoic acid, 95.0%, 5g

2-Hydrazino-3-methylpyridine, 95.0%, 1g